United Therapeutics panel set for February

The FDA's Cardiovascular and Renal Drugs Advisory Committee will review on Feb. 9 UTHR's NDA for its Uniprost ( UT-15) modified prostacyclin to treat pulmonary arterial hypertension. Panel review of U...